EPT Disclosure
2010年2月5日 - 6:08PM
RNSを含む英国規制内ニュース (英語)
TIDMCBF
RNS Number : 7441G
Seymour Pierce Ltd
05 February 2010
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
+------------------------------+----------------------------------------------+
| Name of exempt principal | Seymour Pierce Limited |
| trader | |
+------------------------------+----------------------------------------------+
| Company dealt in | Cobra Bio-Manufacturing plc |
+------------------------------+----------------------------------------------+
| Class of relevant security | Ordinary 1p Shares |
| to which the dealings being | |
| disclosed relate (Note 1) | |
+------------------------------+----------------------------------------------+
| Date of dealing | 04.02.10 |
+------------------------------+----------------------------------------------+
2. DEALINGS (Note 2)
(a) Purchases and sales
+-------------------------+------------------------+--------------------------+
| Total number of | Highest price paid | Lowest price paid (Note |
| securities purchased | (Note 3) | 3) |
| | | |
+-------------------------+------------------------+--------------------------+
| | | |
+-------------------------+------------------------+--------------------------+
+-------------------------+------------------------+--------------------------+
| Total number of | Highest price received | Lowest price received |
| securities sold | (Note 3) | (Note 3) |
| | | |
+-------------------------+------------------------+--------------------------+
| 5,597 | 0.02320 GBP | 0.02320 GBP |
+-------------------------+------------------------+--------------------------+
(b) Derivatives transactions (other than options)
+--------------+----------------+-----------------------+---------------------+
| Product | Long/short | Number of securities | Price per unit |
| name, | (Note 4) | (Note 5) | (Note 3) |
| e.g. CFD | | | |
+--------------+----------------+-----------------------+---------------------+
| | | | |
| | | | |
+--------------+----------------+-----------------------+---------------------+
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
+--------------+-------------+--------------+----------+-----------+--------+---------------+
| Product | Writing, | Number of | Exercise | Type, | Expiry | Option |
| name, | selling, | securities | price | e.g. | | money |
| e.g. call | purchasing, | to which the | | American, | date | paid/received |
| option | varying | option | | European | | per unit |
| | etc. | relates | | etc. | | (Note 3) |
| | | (Note 5) | | | | |
+--------------+-------------+--------------+----------+-----------+--------+---------------+
| | | | | | | |
+--------------+-------------+--------------+----------+-----------+--------+---------------+
(ii) Exercising
+-------------------------+------------------------+--------------------------+
| Product name, e.g. call | Number of securities | Exercise price per unit |
| option | | (Note 3) |
| | | |
+-------------------------+------------------------+--------------------------+
| | | |
| | | |
+-------------------------+------------------------+--------------------------+
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
+------------------------------------------------------------------------------+
| Full details of any agreement, arrangement or understanding between the |
| person disclosing and any other person relating to the voting rights of any |
| relevant securities under any option referred to on this form or relating to |
| the voting rights or future acquisition or disposal of any relevant |
| securities to which any derivative referred to on this form is referenced. |
| If none, this should be stated. |
+------------------------------------------------------------------------------+
| |
| |
| |
+------------------------------------------------------------------------------+
+--------------------------------------------+---------------------------------+
| Date of disclosure | 05.02.10 |
+--------------------------------------------+---------------------------------+
| Contact name | Caroline Woodyer |
+--------------------------------------------+---------------------------------+
| Telephone number | 020 7107 8056 |
+--------------------------------------------+---------------------------------+
| Name of offeree/offeror with which | Cobra Bio-Manufacturing plc |
| connected | |
+--------------------------------------------+---------------------------------+
| Nature of connection (Note 6) | Nomad and Broker |
+--------------------------------------------+---------------------------------+
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMKKPDKCBKKFBK
Cobra Bio-manufacturing (LSE:CBF)
過去 株価チャート
から 5 2024 まで 6 2024
Cobra Bio-manufacturing (LSE:CBF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Cobra Bio-Man. (ロンドン証券取引所): 0 recent articles
その他のCobra Bio-manufacturingニュース記事